ADHD news from FiercePharma
NewsSPOTLIGHT: Shire gets Vyvanse nod for adult use
Shire got its longed-for blessing from the FDA to sell Vyvanse, an ADHD treatment, for use in adults. Some one-third of Vyvanse scrips already go to grownups, off-label, but the FDA OK will let Read more...
AHA: Kids need EKG before ADHD meds
The American Heart Association isn't making any friends among ADHD drug makers today. The health charity is recommending that kids get an EKG before taking stimulant drugs like Ritalin for Read more...
Pros use pills to boost brainpower
Fuzzy-headed today? Then pop a pill. Professionals of all kinds are doing it these days, according to a survey taken by Nature. Read more...
What's Shire doing to support Vyvanse?
Are worries about Shire's Adderall successor justified? The Wall Street Journal Health Blog asked Read more...
New drug warnings poised for rollout
New warnings and warning recommendations are flying out of the FDA this week like geese flying south for the winter, partly because of an FDA advisory panel is meeting. Here's the latest:Committee Read more...
Shire casts off non-core drugs for $213M
UK-based Shire Pharmaceuticals is selling a block of medicines to Almirall of Read more...
Roche to Dr. Reddy's: Back off Boniva
Roche has no intention of letting Boniva go gently into that generic night. On the heels of a Read more...
Feds to study ADHD drugs for heart risks
Do they or don't they? The feds aim to find out whether drugs for attention deficit hyperactivity disorder actually increase the risk of heart problems. The FDA and the Agency for Healthcare Read more...
| Press ReleasesPRESS RELEASE: AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive Read more... FDA STATEMENT: AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive Read more... |
Get more ADHD coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets